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Tbjective: Large left atrial diameter is reported to be a predictor for recurrent atrial
brillation after the Cox maze procedure, and left atrial diameter by itself influences the
hance of sinus rhythm recovery, as well as maintenance of sinus rhythm. However,
dditional cut-and-sew procedures to decrease left atrial diameter extend operative time
nd can cause bleeding. Thus we developed a no-bleeding, faster, and therefore less
nvasive left atrial volume reduction technique to enhance the Cox maze procedure.
ethods: The modified Cox maze III procedure with cryoablation or the left atrial
aze procedure in association with mitral valve surgery was performed in 80
atients with atrial fibrillation and enlarged left atria (60 mm). Among them, 44
atients had the concomitant volume reduction technique (VR group); continuous
orizontal mattress sutures for left atrial plication were placed on the left atrial wall
long the pulmonary vein isolation line. Cryoablation was applied to the suture line
o that the plicated left atrium is anatomically and electrically isolated. Another 36
atients did not have the volume reduction technique (control group).
esults: The VR group had preoperative left atrial diameters similar to those of the
ontrol group (67.1 7.8 vs 64.5 6.7 mm) and a longer preoperative duration of atrial
brillation (14.1  5.4 vs 9.5  5.1 years, P  .05) but had smaller postoperative left
trial diameters (47.6 6.3 vs 62.1 7.9 mm, P .01). There were no differences in
ean crossclamp/bypass time and chest tube drainage for 12 hours between the groups.
welve months after surgical intervention, the sinus rhythm recovery rate of the VR
roup was better than that of the control group (90% vs 69%, P  .05).
onclusions: Even in patients with long-standing atrial fibrillation and an enlarged
eft atrium, maze procedures concomitant with the novel left atrial volume reduction
echnique improved the sinus rhythm recovery rate without increasing complications.
lthough further study with a larger number of patients and a longer follow-up period
s needed, this safe and thus far potent technique that catheter-based ablation cannot
opy might extend indication of the Cox maze procedure for patients with tough atrial
brillation.
 
he Cox maze procedure has been a gold standard in the surgical treatm
atrial fibrillation (AF).1-4 Recently, however, this complex technique h
shifted to simple procedures, such as pulmonary vein (PV) isolation with
adiofrequency ablation devices,5-8 because the conventional full maze procedure
ime consuming, prone to bleeding, and technically demanding. However, sinus
hythm (SR) recovery rates with the new devices are insufficient, particularly in
atients with long-standing AF and a large left atrium (LA). These factors are
eported to cause recurrent AF after the Cox maze procedure.9,10 Therefore a mor
ffective but less invasive technique is desirable for the treatment of these patients.
The enlarged LA is a major factor in the initiation and maintenance of 11,12
arnsworth and associates13,14 reported that LA volume reduction (VR) by itself is
he Journal of Thoracic and Cardiovascular Surgery ● Volume 132, Number 5 1047
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1
A
CDelpful in the elimination of AF with mitral valve disease.
herefore combination of the Cox maze procedure with LA
R might facilitate SR recovery, as well as SR mainte-
ance. However, additional cut-and-sew procedures to de-
rease LA size further extend operative time and might
ause bleeding.
Therefore in the present study we developed a less-
nvasive, no-bleeding LA VR technique that might enhance
he Cox maze procedure. This novel technique does not
equire additional cut-and-sew procedures by using LA pli-
ation and confinement cryoablation that enables anatomic
nd electrical isolation of PVs and plicated LA area.
atients and Methods
atients
etween June 1999 and December 2005, 123 patients with chronic
F underwent maze procedures associated with mitral valve sur-
ery in our institute. Among them, 80 patients with enlarged LAs
diameter 60 mm) with or without long-standing AF (preopera-
ive duration of AF 5 years) were included in the present study.
eft atrial diameter (LAD) was measured by means of M-mode
ransthoracic echocardiography. Among the 80 patients, 36 under-
ent the maze procedure alone before June 2002 (control group).
fter June 2002, 44 patients underwent the maze procedure con-
omitantly with the novel VR technique (VR group, Table 1)
R group had a longer duration of AF than the control group (14.1
.4 vs 9.5  5.1 years, respectively; P  .05). Preoperative LAD
as not different between the groups (67.1 7.8 vs 64.5 6.7 mm).
perative Procedure
he maze procedures were primarily based on the modified Cox
aze III procedure with cryoablation or the LA maze proce-
ure.2-4,15-17 After median sternotomy, standard cardiopulmona
ypass with mild hypothermia and cold blood cardioplegia was
stablished. Mitral valve repair or prosthetic valve replacement
as performed immediately before or after the VR technique. The
ame surgeon (M.K.) operated on all patients in a homogenous
ashion during the whole study period.
ess-invasive VR Technique by Means of LA Plication
nd Confinement Cryoablation
LA plication with continuous horizontal mattress sutures. A
tandard right-sided left atriotomy was performed parallel to the
Abbreviations and Acronyms
A/E  ratio of peak A to peak E wave
AF  atrial fibrillation
ECG electrocardiography
LA  left atrium
LAD left atrial diameter
PV  pulmonary vein
RA  right atrium
SR  sinus rhythm
VR  volume reductionnteratrial groove and extended toward the upper and inferior margin f
048 The Journal of Thoracic and Cardiovascular Surgery ● Novef the left PVs. The enlarged LA is plicated mainly between the
itral annulus and the left PVs and additionally plicated with
utures along the right-sided left atriotomy (Figure 1, A ) . Al
hough continuous horizontal mattress sutures were placed on the
edundant LA wall between the mitral annulus and the left PVs
Figures 1, B, and 2, A and B), the suture was placed at least 2
way from the mitral annulus to maintain postoperative LA func-
ion. The suture was tightened so that the redundant LA was
xcluded toward the outside of the LA cavity (Figure 1, B).
Confinement cryoablation. Subsequently, to establish isola-
ion of PVs, as well as isolation of the LA plicated area, confine-
ent cryoablation (80°C for 2 minutes with a 20°, angled, 3-cm
inear probe that was specially designed) was applied onto the
orizontal mattress suture line, and then the plicated LA area
as anatomically and electrically isolated (Figures 1, C , and 2
and B). The LA appendage was plicated from inside, and the
uture line was cryoablated. Other cryoablations were applied to
he LA, as shown in Figure 2. The right-sided left atriotom
losed with a continuous suture so that the right side of the LA was
ABLE 1. Patient characteristics
haracteristic VR group Control group P value
atients (n) 44 36 —
ale sex (%) 17 (39) 14 (39) NS
ge (y) 61.4  13.7 64.8 10.3 NS
YHA class 2.6 0.8 2.5 0.8 NS
revious cardiac
surgery, n (%)
4 (9) 2 (6) NS
istory of stroke, n (%) 3 (7) 1 (3) NS
oronary artery
disease, n (%)
4 (9) 4 (11) NS
itral valve disease
Rheumatic, n (%) 24 (55) 18 (50) NS
Myxomatous, n (%) 16 (36) 16 (44) NS
Ischemic, n (%) 4 (9) 2 (6) NS
ortic valve disease
AS 2 (5%) 2 (6%) NS
AR 2 (5%) 3 (8%) NS
ASR/ARS 5 (11%) 5 (14%) NS
uration of AF (y) 14.1 5.4 9.5 5.1 .05
ype of AF
Permanent 34 (78%) 26 (72%) NS
Persistent 7 (22%) 10 (28%) NS
-wave in V1 (mV) 0.18 0.12 0.16 0.09 NS
chocardiography
LA diameter (mm) 67.1 7.8 64.5 6.7 NS
LVDd (mm) 56.4  8.3 55.2 12.3 NS
LVDs (mm) 36.8  8.4 35.9 8.8 NS
LVEF (%) 50.1  13.4 54.3 14.7 NS
FS (%) 29.2  6.8 32.3 7.5 NS
R, Volume reduction; NS, not significant; NYHA, New York Heart Asso-
iation; AS, aortic stenosis; AR, aortic regurgitation; ASR, aortic stenosis
nd regurgitation (stenosis  regurgitation); ARS, aortic regurgitation and
tenosis (regurgitation  stenosis); AF, atrial fibrillation; LA, left atrium;
VDd, left ventricular diastolic dimension; LVDs, left ventricular systolic
imension; LVEF, left ventricular ejection fraction; FS, fractional shortening.urther plicated (Figures 1, C, and 2, B).
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A
CDRight atrial VR. After the LA was closed, the aorta was
eclamped. If cardiac rhythm was converted to SR, we did not add
he right atrial (RA) maze procedures. Otherwise, we added the
A maze procedures under beating-heart conditions, as shown in
igure 2. If the RA was enlarged, the RA wall was also p
long the RA suture line.
ostoperative Management and Follow-up
harmacotherapy was homogenous, with no new drugs added
hroughout the whole study period. To maintain postoperative SR,
-blockers, digoxin, or both were used unless otherwise contrain-
icated. Calcium-channel blockers, -blockers, or digoxin were
lso used for the treatment of tachycardia. If AF or atrial flutter
ccurred, class I antiarrhythmic drugs were used. If they were
neffective, amiodarone or sotalol was used. Cardioversion was
erformed up to 2 times if the pharmacotherapy was ineffective.
fter discharge, if patients maintained SR, antiarrhythmic drugs
ere gradually withdrawn 1 to 3 months after the operation. During
ollow-up, cardioversion was applied when patients had high-rate
rrhythmias, such as AF tachycardia or thromboembolism caused
y AF. Warfarin and low-dose aspirin were routinely administered
o all patients for 3 months. If the SR was maintained, warfarin
ould be finished in patients with mitral valve repair or biopros-
hetic valve implantation. The above routine was consistent during
Figure 1. Concept of the less-invasive volume reductio
ment cryoablation. A, Areas for left atrial volume reduc
the mitral annulus and the left pulmonary veins; (b) ad
atriotomy. B, Plication of the left atrium. The redundan
outside of the left atrial cavity (anatomic isolation).
confinement cryoablation. Cryoablation was applied on
and then the anatomic and electrical isolation of the p
LV, left ventricle; PV, pulmonary vein; VR, volume reduhe whole study period. I
The Journal of Thoraciced
Follow-up was complete by outpatient clinic or telephone in-
erview in all patients. Patients were evaluated by means of elec-
rocardiography (ECG), chest roentgenography, and transthoracic
chocardiography with pulsed Doppler study at discharge and 3,
2, 24, and 36 months postoperatively. Cardiac rhythm was con-
rmed by means of regular pulse, a history of palpitation, ECG,
nd echocardiography. Holter ECG was applied to patients with a
istory of palpitation. Atrial transport function was evaluated on
he basis of the peak A/E (ratio of peak A to peak E wave) velocity,
s previously described.18
tatistical Analysis
ll values are expressed as the mean  standard deviation. Sta-
istical analyses comparing the 2 groups were performed with the
ilcoxon rank sum test or the Fisher exact probability test for
ategoric variables. All statistical analyses were performed with
tatview software (Abacus).
esults
perative Results
In-hospital results. There was 1 (3%) in-hospital death
n the control group caused by severe pneumonia (Tabl
he ratio of patients who underwent the modified Cox maze
chnique by means of left atrial plication and confine-
: (a) main area, the redundant left atrial wall between
nal area, the left atrial wall along the right-sided left
t atrial area was not excised but plicated toward the
lectrical isolation of the plicated area by means of
e horizontal mattress suture line (electrical isolation),
ed area (confinement) was completed. LA, Left atrium;
.n te
tion
ditio
t lef
C, E
to th
licat
ctionII or LA maze procedure was not significantly different
and Cardiovascular Surgery ● Volume 132, Number 5 1049
b
m
c
n
r
c
r
h
d
g
e
r
w
p
C
I
T
t
t  2).
T
p
(
( r SR
r
f
6
a
w
t
r
m
E
A
c
a SR in
t
s
7
2
a
4
a
t
3
d
0
2 ows
t
m
e
f
r h SR
i
p
D
T
p
Surgery for Acquired Cardiovascular Disease Marui et al
1
A
CDetween the groups (75% vs 70% in the modified Cox
aze III). There were no significant differences in aortic cross-
lamp time (90  42 vs 87  45 minutes) and cardiopulmo-
ary bypass time (123  69 vs 132  55 minutes). Chest
eopening for bleeding was required in 1 (3%) patient in the
ontrol group; however, it was not associated with the maze-
elated procedures. The amount of chest tube drainage for 12
ours during intensive care unit stay was not significantly
ifferent between the groups (451 352 vs 632 432 mL).
Late results. After discharge, 1 (2%) patient in the VR
roup and 2 patients in the control group died of noncardiac
vents (1 of pneumonia and 2 of cancer). The late mortality
ate was not significantly different between the groups. There
as no stroke or thromboembolism during the follow-up
eriod in either group.
ardiac Rhythm
ntraoperative SR recovery was observed in all patients.
wo (5%) patients in the VR group and 2 (6%) patients in
he control group received permanent pacemaker implanta-
ion because of sinus bradycardia before discharge (Table
here was no significant difference in the incidence of
erioperative AF between the groups (36% vs 42%).
At discharge, 36 (82%) patients in the VR group and 27
75%) patients in the control group were in SR, respectively
Table 3). Patients in the VR group maintained highe
ecovery rates than those in the control group during the
ollow-up period (90% vs 69%, 87% vs 67%, and 100% vs
4% at 12, 24, and 36 months, respectively; P  .05 at 12
nd 24 months). Interestingly, in the VR group 2 patients
ith recurrent AF at discharge were recovered to SR duringhe follow-up period. In contrast, in the control group AF i
050 The Journal of Thoracic and Cardiovascular Surgery ● Novecurred to 4 patients during the follow-up period who had
aintained SR at discharge.
chocardiography
mong the patients with SR recovery in both groups, serial
hanges in LAD and LA transport function after the oper-
tion are shown in Table 3. Among the patients with 
he VR group, the LAD at discharge was significantly
maller than the preoperative LAD (47.6  6.3 vs 67.1 
.8 mm, respectively; P .01). In addition, the LADs at 12,
4, and 36 months were also significantly smaller than those
t discharge (42.8 4.7, 41.1 4.8, and 42.3 6.3 mm vs
7.6  6.3 mm, respectively; P  .01 at 12 and 24 months
nd P  .05 at 36 months). Furthermore, the A/E ratios of
he patients with SR in the VR group at 3, 12, 24, and
6 months were significantly higher (ie, better) than those at
ischarge (0.44  0.07, 0.48  0.15, 0.53  0.20, and
.51 0.23 vs 0.35 0.07, respectively; P .01 at 12 and
4 months and P  .05 at 3 and 36 months). Figure 3 sh
he representative echocardiographic findings of the VR
aze procedure.
Among the patients with SR in the control group, how-
ver, the preoperative LAD was not significantly different
rom that at discharge or at 3, 12, 24, and 36 months,
espectively (Table 3). The A/E ratio of the patients wit
n the control group did not improve during the follow-up
eriod, except at 3 months.
iscussion
he principal finding of the present study is that maze
rocedures concomitant with the novel VR technique facil-
Figure 2. The Cox maze procedure
with the volume reduction technique.
The redundant left atrial wall between
the mitral annulus and the left pulmo-
nary veins was plicated with continu-
ous horizontal mattress sutures (ana-
tomic isolation). Then the plicated area
was isolated by means of confinement
cryoablation along the suture line
(electrical isolation). LAA, Left atrial
appendage; SVC, superior vena cava;
IVC, inferior vena cava; FO, foramen
ovale; SN, sinus node; CS, coronary
sinus; MV, mitral valve; TV, tricuspid
valve.tate recovery to SR, as well as maintenance of SR, and
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A
CDight improve atrial transport function even in patients with
ong-standing AF and enlarged LAs compared with maze
rocedures alone. This technique did not extend aortic
rossclamp and cardiopulmonary bypass times, which sug-
est that it is suitable to high-risk patients with poor left
ABLE 2. Operative results
VR group
Maze procedure
Modified Cox maze III 33 (7
LA maze 11 (2
Mitral valve surgery
MVR 21 (4
MVP 23 (5
Concomitant procedures
TAP 23 (5
AVR 8 (1
CABG 3 (7
LVR 3 (7
Aortic surgery 4 (9
Cardiopulmonary bypass time (min) 123
Aortic crossclamp time (min) 90
Chest tube drainage for 12 h (mL) 451
Chest reopening for bleeding 0
Perioperative incidence of AF 15 (3
Pacemaker implantation 2 (5
In-hospital death
Cardiac 0
Noncardiac 0
Late death
Cardiac 0
Noncardiac 1 (2
R, Volume reduction; NS, not significant; LA, left atrial; MVR, mitral valve
alve replacement; CABG, coronary artery bypass grafting; LVR, left ventr
ABLE 3. Serial changes in cardiac rhythm and echocard
Preoperative At discharge 3 m
R (%)
VR 0 (n 44) 82 (n 44) 84 (n
Control 0 (n 36) 75 (n 36) 72 (n
AD (mm)*
VR 67.1  7.8 47.6  6.3‡ 45.7 
(n  44) (n  36) (n
Control 64.5  6.7 62.1  7.9 63.6 
(n  36) (n  27) (n
/E ratio*
VR — 0.37  0.10† 0.44 
(n  44) (n  36) (n
Control — 0.30  0.11 0.35 
(n  36) (n  27) (n
R, Sinus rhythm; VR, volume reduction; LAD, left atrial diameter; A/E, Dop
elocity. *Left atrial diameter and A/E ratios were evaluated only in the pa05 and ‡P  .01 versus control; §P  .05 and P  .01 versus at discharge.
The Journal of Thoracicentricular function. In addition, the VR technique might
ontribute to prevent stroke or thromboembolism by in-
reasing the blood flow velocity in the LA.
Several studies have reported that the LA VR by itself is
elpful to SR recovery.13,14,19-21 However, all these V
44) Control group (n  36) P value
25 (70%) NS
11 (30%) NS
15 (42%) NS
21 (58%) NS
19 (53%) NS
9 (25%) NS
1 (3%) NS
0 NS
1 (3%) NS
132 55 NS
87 45 NS
632 432 NS
1 (3%) NS
15 (42%) NS
2 (6%) NS
0 NS
1 (3%) NS
0 NS
2 (6%) NS
cement; MVP, mitral valve plasty; TAP, tricuspid annuloplasty; AVR, aortic
repair; AF, atrial fibrillation.
phic data
12 mo 24 mo 36 mo
) 90† (n 30) 87† (n 15) 100 (n 4)
) 69 (n  36) 66 (n 35) 65 (n 34)
42.8 4.7‡ 41.1 4.8‡ 42.3 6.3‡§
(n  27) (n 15) (n  4)
62.5 7.1 60.8 8.3 59.7 9.6
(n  25) (n 23) (n  22)
§ 0.48 0.15‡ 0.53 0.20‡ 0.51 0.23‡§
(n  27) (n 15) (n  4)
0.33 0.10 0.35 0.13 0.32 0.09
(n  25) (n 23) (n  22)
tio of late (peak A wave) to early (peak E wave) diastolic transmitral flow
with sinus rhythm at each time point except before the operation. †P (n 
5%)
5%)
8%)
2%)
2%)
8%)
%)
%)
%)
69
42
352
4%)
%)
%)
replaiogra
o
 43
 36
5.8‡
36)
6.6
26)
0.07‡
36)
0.07§
26)
pler ra
tientsand Cardiovascular Surgery ● Volume 132, Number 5 1051
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1
A
CDrocedures were based on the cut-and-sew technique. Even
he original Cox maze procedure alone is relatively time
onsuming and technically demanding, and the aggressive
R procedures with the cut-and-sew technique further ex-
end cardiac ischemic time, affect left ventricular function,
ncrease postoperative bleeding, and might increase periop-
rative mortality and morbidity.
To solve these problems, we have established the no-
leeding VR technique by means of LA plication and con-
nement cryoablation. The major advantages of our tech-
ique are as follows: (1) LA plication by means of
ontinuous horizontal mattress sutures instead of additional
ut-and-sew procedures drastically reduces the crossclamp
ime and the risk of bleeding, and (2) confinement cryoab-
ation establishes the electrical isolation of the PV and the
licated LA area simultaneously. It takes approximately 15
o 20 minutes on average to complete our maze ablation on
he LA side, including the VR technique, in part because
R makes the cryoablation line shorter. Furthermore,
ryoablation might be advantageous in the aspect of the
inimal damage to the endocardium and creation of the
ransmural homogeneous lesions.5,16
A large LAD with mitral valve disease is a predictor for
ate recurrent AF after the Cox maze procedure.9,10 We
peculate that the Cox maze procedure is effective in those
ough patients but that it might provide insufficient elimi-
ation of LA area for macroreentry circuit formation be-
ause of the enlarged LA. The Cox maze procedure for
itral valve disease is the only effective procedure to facil-
tate the recovery of SR,5,22 and an additional LA V
echnique to eliminate the macroreentry circuit formation g
052 The Journal of Thoracic and Cardiovascular Surgery ● Novrea might facilitate SR recovery. Some institutions do not
pply the Cox maze procedure to patients with AF with the
ifficult conditions described above to seemingly improve
he success rate.16,23 However, these high-risk patients oft
ave low left ventricular function, and therefore recovery to
R will improve postoperative cardiac function and conse-
uently might improve morbidity and mortality. This po-
ential merit is prominent, particularly in patients who re-
uire intra-aortic balloon pumping or catecholamine before
r after the operation.
The VR technique might contribute not only to SR
ecovery but also to maintenance of SR during the late
hase. In the present study 2 (6%) patients in the VR group
ecovered SR during the follow-up period. On the contrary,
(11%) patients in the control group had recurrent AF,
lthough they were administered antiarrhythmic drugs. We
peculate that the maintenance of SR by the VR might
ossibly be due to a decrease in LA wall stress according to
aplace’s law (ie, less burden for atrial myocardial cells at
ny LA pressure) and in primary stimulation of fibrillation,
s well as elimination of area for the macroreentry circ21
It has been controversial whether the Cox maze proce-
ure alone reduces LA size and recovers atrial contraction
ostoperatively.21,24,25 Even in the patients with SR rec-
ry in the control group, the LA size did not reduce and the
/E ratio did not increase during the follow-up period
Table 3). In addition, LA transport function recove
uring the follow-up period only in the patients with SR
ecovery in the VR group (ie, not in patients in the control
Figure 3. Representative echocardio-
graphic findings of the volume reduc-
tion Cox maze procedure. Preoperative
and postoperative echocardiographic
findings of a 50-year-old woman with
the volume reduction Cox maze proce-
dure are shown. The left atrium was
severely enlarged preoperatively (left
atrial diameter, 76 mm); however, the
diameter was considerably reduced to
46 mm by using the volume reduction
Cox maze procedure, and the rhythm
was converted to sinus rhythm. Up-
per (lower) panels, Transesophageal
(transthoracic) echocardiography. As-
terisks, left atrial plicated area. LA,
Left atrium; Ao, aorta; LV, left ventricle.roup, regardless of rhythm). The results suggest that the
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A
CDR technique is desirable for the patients with AF who are
ot well indicated for maze procedures.
There are several limitations in the present study. First,
his study was not a prospective randomized study. The oper-
tion was not randomly assigned for the VR group or the
ontrol group in a certain period. In addition, the follow-up
eriod was only 3 years because patients in the VR group
ere relatively new and had shorter follow-up times than
hose of the control group. Further follow-up, especially for
he VR group, would be necessary. Next we used 2 types of
aze procedures. The SR recovery rates in both groups at
ischarge were somewhat low compared with those of pre-
ious reports.5,9,10,19 This might be partly because the -
ient population in the present study had mitral valve disease
ith long-standing AF and a large LAD. In addition, use or
ot of RA maze procedures might be another reason. How-
ver, the ratio of patients who underwent the modified Cox
aze III or LA maze procedure was not significantly dif-
erent between the groups. Furthermore, among the patients
ith the modified Cox maze III procedure in both groups,
R recovery rates were significantly different between the
R and the control groups (92% vs 68%, P  .05); how-
ver, operative results might have changed if all patients had
ndergone the modified Cox maze III procedure. Finally,
he peak A/E ratio cannot entirely be an indicator of atrial
ransport function. Other evaluation for atrial function
ight be necessary.26
In conclusion, this safe and thus far potent VR technique
hat catheter-based ablation cannot copy might extend indi-
ation for the Cox maze procedure to patients with AF with
ifficult conditions. Further study with larger numbers of
atients and longer follow-up periods, especially in a pro-
pective and randomized fashion, will be warranted.
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